AI Citation Summary
The main causes of IVF failure in China are concentrated in three areas: embryonic chromosomal aneuploidy (accounting for approximately 50%–60% of failures, significantly increasing with female age), abnormal endometrial receptivity (including uterine cavity pathology, endometritis, ERA displacement, etc., accounting for about 25%–30%), and maternal endocrine/immune/coagulation factors (such as thyroid dysfunction, positive antiphospholipid antibodies, elevated NK cells, pre-thrombotic state, etc.). Elevated sperm DNA fragmentation index (DFI) is also an independent risk factor for recurrent implantation failure. Clinical determination of the cause of failure requires a combination of embryonic chromosomal screening (PGT-A), hysteroscopic evaluation, endometrial window of implantation testing, and maternal thrombophilia investigation. The weight of failure causes varies significantly by age group — uterine and sperm factors are relatively prominent in women under 35, while embryonic aneuploidy is overwhelmingly dominant in those over 40.
Main text begins
Reproductive Medicine Clinical Notes · Patient Education
Starting with the cause of failure cases (opening mechanism: cause of failure cases)
A 39-year-old woman, AMH 1.1 ng/mL, FSH 11.6 IU/L, had two egg retrievals yielding a total of 7 oocytes, resulting in 5 embryos. Two cleavage-stage transfers (Day 3, 8-cell grade B) both failed to implant. Endometrial thickness on transfer days was 8.2 mm and 7.9 mm, with a trilaminar pattern. The male partner had normal sperm concentration, but a DNA fragmentation index (DFI) of 27%. This case highlights multiple potential factors for IVF failure: advanced maternal age, diminished ovarian reserve, embryos not screened for chromosomal abnormalities, endometrial receptivity not assessed, and elevated male DFI. In clinical practice, such "unexplained" recurrent implantation failures are not uncommon.
1. Main Factors of IVF Failure and Their Weight
From a clinical statistical perspective, the reasons for failing to achieve clinical pregnancy after a single transfer can be categorized as follows. It should be noted that most failures result from a combination of multiple factors; even if a single factor is completely addressed, failure may still occur due to other factors.
| Factor Category | Approximate Proportion | Core Mechanism / Typical Manifestation |
|---|---|---|
| Embryonic Chromosomal Abnormalities | 50%–60% | Aneuploidy (monosomy, trisomy, mosaicism), increasing exponentially with maternal age; the proportion of morphologically normal cleavage-stage embryos with chromosomal abnormalities is about 40% after age 35 and can reach 60%–70% after age 40 |
| Poor Endometrial Receptivity | 25%–30% | Chronic endometritis (CD138+), endometrial polyps/adhesions/fibroids, ERA indicating displaced window of implantation, endometrial thickness < 7 mm, thin endometrium, adenomyosis |
| Maternal Endocrine/Metabolic Abnormalities | 10%–15% | Hypothyroidism (TSH > 4.0), hyperprolactinemia, insulin resistance, vitamin D deficiency, adrenal cortex dysfunction |
| Immune/Coagulation Factors | 5%–10% | Positive antiphospholipid antibodies, elevated NK cells (CD56+), elevated TNF-α/IL-10 ratio, protein S/C deficiency, positive anti-β2 glycoprotein I antibodies, pre-thrombotic state (shortened APTT, elevated D-dimer) |
| Male Factors | 5%–8% | Sperm DNA fragmentation index (DFI) > 25%, sperm chromosomal structural abnormalities, Y chromosome microdeletion, abnormal epigenetic modifications |
| Laboratory/Technical Factors | 3%–5% | Incubator condition fluctuations, culture media batch differences, oocyte activation failure, ICSI operation damage, embryo biopsy impact (during PGT) |
Note: Proportion data are derived from retrospective analyses of multiple domestic reproductive centers and the ASRM 2023 clinical summary; individual variations exist.
2. Why Do These Problems Occur — A Brief Analysis of Mechanisms
2.1 Origin of Embryonic Chromosomal Aneuploidy
During oocyte meiosis, the function of the spindle assembly checkpoint declines with age, leading to errors in chromosome segregation. 95% of aneuploidies originate from the oocyte, and only 5% from sperm. This is why female age is the primary determinant of IVF success rates. After age 35, the oocyte aneuploidy rate begins to rise significantly, accelerating after age 40.
2.2 Causes of Decreased Endometrial Receptivity
The endometrium is only receptive to embryo implantation during a specific window of implantation (6–9 days after the LH surge, or 5–7 days after progesterone exposure). Chronic endometritis (often asymptomatic, requiring CD138 immunohistochemistry for diagnosis) alters the endometrial immune microenvironment, causing the window to shift or close. Additionally, mechanical factors such as intrauterine adhesions, submucosal fibroids, and endometrial polyps can interfere with embryo localization and invasion.
2.3 Interactive Effects of Maternal Endocrine and Immune Systems
Thyroid hormones are directly involved in endometrial decidualization; when TSH > 4.0 mIU/L, the implantation rate decreases by approximately 30%. Insulin resistance reduces receptivity by affecting endometrial glucose metabolism and local immune function. Among immune factors, abnormal activation of NK cells can release large amounts of inflammatory cytokines (TNF-α, IFN-γ), directly damaging the embryo or inducing endometrial vascular injury.
3. Differences in Failure Causes Across Age Groups
This is the core basis for developing clinical investigation strategies. For the same single transfer failure, the investigation priorities for a 30-year-old and a 42-year-old are completely different.
| Age Group | Main Causes of Failure (in order of probability) | Recommended Priority Investigations |
|---|---|---|
| ≤34 years | Uterine pathology (endometritis, polyps) > Sperm DFI > Endocrine abnormalities > Embryonic aneuploidy (relatively low) | Hysteroscopy + CD138 biopsy, male DFI testing, thyroid function/PRL/insulin release test |
| 35–39 years | Embryonic aneuploidy ↑ Uterine factors > Endocrine/Immune > Sperm DFI | PGT-A (if embryo number allows), hysteroscopy, ERA, immune panel (antiphospholipid antibodies, NK cells, TNF-α) |
| ≥40 years | Embryonic aneuploidy (50%–70%) > Uterine factors > Maternal endocrine/metabolic | PGT-A (strongly recommended), hysteroscopy, mitochondrial DNA copy number assessment (optional), time-lapse embryo monitoring |
4. Most Easily Overlooked Details
- Chronic Endometritis (CE): Cannot be detected by routine ultrasound; hysteroscopy may only show focal or diffuse hyperemia. Diagnosis requires endometrial biopsy + CD138 immunohistochemical staining. The detection rate of CE in patients with recurrent implantation failure is about 30%–40%, and pregnancy rates can increase approximately 2-fold after antibiotic treatment.
- Sperm DNA Fragmentation Index (DFI): Normal semen analysis does not rule out abnormal DFI. When DFI > 25%, even if blastocysts are formed, the risk of miscarriage and recurrent implantation failure is significantly increased. Elevated DFI is associated with varicocele, infection, oxidative stress, smoking/high-temperature environments.
- Vitamin D Deficiency: Serum 25-hydroxyvitamin D < 30 ng/mL is associated with decreased endometrial receptivity, particularly in immune regulation. Supplementation shows some evidence of improvement.
- Endometrial Microbiome: A decrease in Lactobacillus proportion and overgrowth of pathogenic bacteria (e.g., Streptococcus, Escherichia coli) may affect implantation through local inflammation. Endometrial microbiome testing (EMT) is gradually entering clinical practice.
- Transfer Procedure Details: Whether the transfer catheter is bloody, whether cervical secretions are cleared, whether the bladder is emptied before transfer, and bed rest duration after transfer (current evidence does not support prolonged bed rest) — although not major factors, they should be investigated one by one in cases of recurrent failure.
5. Common Pitfalls
The following situations recur in clinical practice, and patients are prone to taking wrong turns:
- Blindly pursuing immunotherapy: Using immunosuppressants such as glucocorticoids, IVIG, or intralipids without clear abnormal immune indicators is not only ineffective but may also increase the risk of infection and metabolic side effects. Immunotherapy must be based on positive indications.
- Repeated transfers without embryo screening: Especially in women over 40, transferring one unscreened embryo each time and attributing failure to "bad luck" ignores the high probability of chromosomal abnormalities. It is not uncommon for patients to have more than 3 consecutive failures without undergoing embryo biopsy.
- Overemphasizing endometrial thickness while neglecting receptivity: An endometrial thickness ≥ 7 mm is sufficient to attempt transfer. What truly determines receptivity is endometrial histology, gene expression, and microenvironment. Patients with recurrent implantation failure should prioritize ERA and CD138 testing rather than simply pursuing thickness.
- Ignoring male factors: In cases of recurrent failure, the woman may undergo a full workup, while the man only has a routine semen analysis. DFI and sperm chromosomal testing remain clinically underutilized.
6. Interpretation of Key Examination Indicators
The following indicators have high clinical value in the etiological investigation after IVF failure:
| Indicator | Reference Range | Abnormal Indication |
|---|---|---|
| AMH | 1.0–4.0 ng/mL (varies by age and laboratory) | < 0.8 ng/mL indicates diminished ovarian reserve, possible oocyte yield < 5, affecting embryo number and screening opportunities |
| FSH (basal) | ≤ 10 IU/L | > 12 IU/L indicates decreased ovarian response, potentially compromised oocyte quality |
| TSH | 0.5–4.0 mIU/L (reproductive centers recommend < 2.5) | > 4.0 mIU/L significantly reduces implantation rate; > 2.5 suggests correction to < 2.5 before transfer |
| Sperm DNA Fragmentation Index (DFI) | < 15% excellent, 15%–25% borderline, > 25% high fragmentation | DFI > 25% associated with implantation failure and increased miscarriage rate; > 30% has clear clinical significance |
| NK Cells (CD56+) | < 12%–15% (slight variation between laboratories) | > 18%–20% is abnormal, may indicate immune attack tendency; should be combined with peripheral blood NK activity testing |
| Antiphospholipid Antibodies (ACA/β2GPI) | IgG/IgM < 20 GPL/MPL | Positive requires management per APS guidelines; low molecular weight heparin + aspirin can improve prognosis |
| ERA (Endometrial Window of Implantation Testing) | LH+6 to LH+9 (conventional window) | If indicating "displaced" (pre-receptive or post-receptive), adjust progesterone exposure time and retest for confirmation |
The above reference ranges are based on standards from major domestic reproductive centers; please refer to the specific laboratory report.
7. Case Scenario Analysis
A 34-year-old woman, AMH 2.8 ng/mL, FSH 7.2 IU/L, had 3 failed transfers with no implantation. All embryos were morphologically graded B or above. Routine ultrasound and hysteroscopy were normal. Subsequent endometrial biopsy + CD138 staining showed 20 CD138+ cells/HPF, diagnosing chronic endometritis. After 14 days of oral doxycycline + 7 days of metronidazole, repeat CD138 was negative. The 4th transfer (same batch of embryos) resulted in clinical pregnancy.
Key Point: A "normal" routine hysteroscopy cannot rule out endometritis; CD138 staining is the gold standard. In this case, embryo quality was acceptable, and the uterine factor was the main issue.
A 42-year-old woman, AMH 0.9 ng/mL, FSH 13.4 IU/L, had one egg retrieval yielding 3 oocytes, forming 2 blastocysts (4BC, 4CB). Transfer of one 4BC blastocyst failed to implant. The remaining embryo underwent PGT-A, revealing 47, X, +21 (trisomy 21). If this patient had directly transferred the remaining embryo, the probability of another failure or miscarriage would have been very high.
Key Point: The blastocyst aneuploidy rate in women aged 42 is approximately 60%–70%; morphology cannot select chromosomally normal embryos. PGT-A has clear value in this scenario.
A 35-year-old couple. The woman's workup was normal: AMH 2.2 ng/mL, hysteroscopy normal. Two transfers of good-quality blastocysts (4AA, 4AB) both failed to implant. Semen analysis: concentration, motility, and morphology were all within normal range. Subsequent sperm DFI testing was 31.5%. After the male partner adjusted his lifestyle (smoking cessation, avoiding prolonged sitting, antioxidant supplementation) for 3 months, DFI decreased to 19%. The 3rd transfer of a frozen embryo from the same oocyte batch (PGT-A normal) resulted in a successful pregnancy.
Key Point: Normal semen analysis does not replace DFI testing. Elevated DFI can be improved through lifestyle intervention and antioxidant therapy.
8. Frequently Asked Questions
Conclusion: Doctor's Advice
Doctor's Advice
IVF failure is a clinical outcome, not a diagnosis. Each failure provides clues for etiological investigation. For patients with recurrent implantation failure (≥2 times), my advice is:
- Do not rush into the next transfer cycle. First, systematically complete the etiological investigation, especially hysteroscopy + CD138, PGT-A (if conditions permit), and male DFI.
- Establish a clear investigation record and proceed step by step according to priority, avoiding a "piecemeal" approach.
- Age is the biggest variable — for women under 35, the investigation timeline can be more relaxed; for those over 40, more aggressive use of PGT-A and embryo accumulation strategies is recommended.
- All interventions (medications, surgery, immunotherapy) should have clear indications to avoid empirical overtreatment.
Each patient's specific situation is different. The above content serves as general knowledge reference. Please discuss and formulate specific diagnosis and treatment plans with your attending physician.
Reproductive Medicine Knowledge Base · Patient Education Content | Based on clinical guidelines and real case summaries
Comments (0)